Iqvia Holdings (IQV) Cash from Operations (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Cash from Operations came in at $558.0 million in Q2 2026, up 25.96% year-over-year from $443.0 million in Q2 2025, and down 9.71% quarter-over-quarter from $618.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Cash from Operations (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Cash from Operations across 15 years of filings, most recently posting $558.0 million for Q2 2026.
- In Q2 2026, Cash from Operations rose 25.96% year-over-year to $558.0 million; the TTM figure through Jun 2026 stood at $2.8 billion (up 7.72% YoY), while the FY2025 annual figure was $2.7 billion, down 2.28% from the prior year.
- Cash from Operations came in at $558.0 million for Q2 2026 at Iqvia Holdings, down from $618.0 million in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of $908.0 million in Q3 2025 to a low of $329.0 million in Q2 2022.
- Average Cash from Operations over 5 years is $608.6 million, with a median of $575.5 million recorded in 2023.
- Year-over-year, Cash from Operations sank 41.41% in 2022 and jumped 46.27% in 2024.
- Over 5 years, Cash from Operations stood at $560.0 million in 2022, then surged by 33.39% to $747.0 million in 2023, then climbed by 18.47% to $885.0 million in 2024, then fell by 16.95% to $735.0 million in 2025, then retreated by 24.08% to $558.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were $558.0 million in Q2 2026, $618.0 million in Q1 2026, and $735.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 162.01 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 281.27 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 179.73 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 28.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -44.27 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -492,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 558.00 Mn |
| Mar 31, 2026 | 618.00 Mn |
| Dec 31, 2025 | 735.00 Mn |
| Sep 30, 2025 | 908.00 Mn |
| Jun 30, 2025 | 443.00 Mn |
| Mar 31, 2025 | 568.00 Mn |
| Dec 31, 2024 | 885.00 Mn |
| Sep 30, 2024 | 721.00 Mn |
| Jun 30, 2024 | 588.00 Mn |
| Mar 31, 2024 | 522.00 Mn |
| Dec 31, 2023 | 747.00 Mn |
| Sep 30, 2023 | 583.00 Mn |
| Jun 30, 2023 | 402.00 Mn |
| Mar 31, 2023 | 417.00 Mn |
| Dec 31, 2022 | 560.00 Mn |
| Sep 30, 2022 | 863.00 Mn |
| Jun 30, 2022 | 329.00 Mn |
| Mar 31, 2022 | 508.00 Mn |
| Dec 31, 2021 | 692.00 Mn |
| Sep 30, 2021 | 844.00 Mn |